Investigating the effects of olanzapine on appetite and weight in patients with cancer in a systematic review.

Fiche publication

Date publication

juin 2026

Journal

Discover oncology

Auteurs

Membres identifiés du Cancéropôle Est :
Pr BOUCHE Olivier , Dr RENAUX TORRES Marie Charlotte

Tous les auteurs :
Renaux Torres MC, Smati K, Noujaim P, Martin S, Gigante E, Brugel M, Carlier C, Djerada Z, Perrier M, Bertin É, Bouché O, Coutureau C, Slimano F

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/42237034

Résumé

Anorexia, malnutrition, and cachexia are common in patients with cancer, yet evidence-based pharmacological guidance remains limited. Olanzapine is an antipsychotic that can increase appetite and cause weight gain. This systematic review evaluated the effects of olanzapine on appetite and body weight in patients with cancer.